enGene Therapeutics Statistics

Total Valuation

ENGN has a market cap or net worth of $117.23 million. The enterprise value is -$107.88 million.

Market Cap	117.23M
Enterprise Value	-107.88M

Important Dates

The last earnings date was Monday, June 15, 2026, before market open.

Earnings Date	Jun 15, 2026
Ex-Dividend Date	n/a

Share Statistics

ENGN has 66.99 million shares outstanding. The number of shares has increased by 25.52% in one year.

Current Share Class	66.99M
Shares Outstanding	66.99M
Shares Change (YoY)	+25.52%
Shares Change (QoQ)	+3.66%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	39.69%
Float	22.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.46
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.57, with a Debt / Equity ratio of 0.13.

Current Ratio	12.57
Quick Ratio	12.17
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.42

Financial Efficiency

Return on equity (ROE) is -52.58% and return on invested capital (ROIC) is -30.62%.

Return on Equity (ROE)	-52.58%
Return on Assets (ROA)	-28.86%
Return on Invested Capital (ROIC)	-30.62%
Return on Capital Employed (ROCE)	-46.35%
Weighted Average Cost of Capital (WACC)	3.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-258,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.32% in the last 52 weeks. The beta is -0.29, so ENGN's price volatility has been lower than the market average.

Beta (5Y)	-0.29
52-Week Price Change	-46.32%
50-Day Moving Average	3.53
200-Day Moving Average	7.01
Relative Strength Index (RSI)	35.31
Average Volume (20 Days)	993,736

Short Selling Information

The latest short interest is 1.39 million, so 2.08% of the outstanding shares have been sold short.

Short Interest	1.39M
Short Previous Month	1.62M
Short % of Shares Out	2.08%
Short % of Float	6.18%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-132.58M
Pretax Income	-127.11M
Net Income	-126.85M
EBITDA	-131.91M
EBIT	-132.58M
Earnings Per Share (EPS)	-$2.12

Full Income Statement

Balance Sheet

The company has $258.47 million in cash and $33.35 million in debt, giving a net cash position of $225.11 million or $3.36 per share.

Cash & Cash Equivalents	258.47M
Total Debt	33.35M
Net Cash	225.11M
Net Cash Per Share	$3.36
Equity (Book Value)	255.17M
Book Value Per Share	3.81
Working Capital	248.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.00 million and capital expenditures -$1.39 million, giving a free cash flow of -$111.39 million.

Operating Cash Flow	-110.00M
Capital Expenditures	-1.39M
Depreciation & Amortization	670,000
Net Borrowing	1.25M
Free Cash Flow	-111.39M
FCF Per Share	-$1.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.52%
Shareholder Yield	-25.52%
Earnings Yield	-108.20%
FCF Yield	-95.02%

Analyst Forecast

The average price target for ENGN is $3.29, which is 88.00% higher than the current price. The consensus rating is "Hold".

Price Target	$3.29
Price Target Difference	88.00%
Analyst Consensus	Hold
Analyst Count	11
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1